• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸在精神分裂症发病机制中的潜在作用。

Potential role of amino acids in pathogenesis of schizophrenia.

作者信息

Saleem Shamaila, Shaukat Faiza, Gul Anjuman, Arooj Mahwish, Malik Arif

机构信息

Department of Physiology, College of Medicine, Qassim University, Kingdom of Saudi Arabia.

Department of Community Medicine, College of Medicine, Qassim University, Kingdom of Saudi Arabia.

出版信息

Int J Health Sci (Qassim). 2017 Jul-Sep;11(3):63-68.

PMID:28936154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5604273/
Abstract

Schizophrenia is a syndrome of inconclusive etiopathogenesis with a prevalence of about 1% in general population. Underlying factors include genetic predisposition and defected neurodevelopment in early stages of life. The role of amino acids has been indicated in some reports. However, very few workers have detailed the effect of each amino acid in the pathophysiology of schizophrenia. Thus, in the present review, we aimed to provide an insight into the potential role of amino acids levels during schizophrenia. Any single amino acid defect cannot lead to the development of the disease. Higher concentration of glycine, serine, glutamate, homocysteine, and arginine are reported by many scientists in blood samples of patients of schizophrenia. Levels of rest of the amino acids show inconsistent results. Involvement of glutamate in pathophysiology of schizophrenia was hypothesized as early as the 1980s. It was demonstrated that dissociative anesthetics which are N-methyl-D-aspartate (NMDA) receptor antagonists can produce all negative, psychotic, cognitive, and physiological features of schizophrenia in healthy controls. This led to the development of hypothesis of NMDA receptor hypofunctioning in the pathophysiology of schizophrenia. Later on, it was also found that agents enhancing functioning of NMDA receptor at glycine modulatory site, improved symptoms in patients of schizophrenia receiving antipsychotic medications. Thus, the relationship of perturb amino acid levels with the biological basis and pathophysiology of schizophrenia is an important area to be further explored for effective management of schizophrenic patients.

摘要

精神分裂症是一种病因未明的综合征,在普通人群中的患病率约为1%。潜在因素包括遗传易感性和生命早期的神经发育缺陷。一些报告指出了氨基酸的作用。然而,很少有研究人员详细阐述每种氨基酸在精神分裂症病理生理学中的作用。因此,在本综述中,我们旨在深入了解氨基酸水平在精神分裂症中的潜在作用。任何单一氨基酸缺陷都不会导致该疾病的发生。许多科学家报告称,精神分裂症患者血液样本中甘氨酸、丝氨酸、谷氨酸、同型半胱氨酸和精氨酸的浓度较高。其余氨基酸的水平结果不一致。早在20世纪80年代就有人提出谷氨酸参与精神分裂症的病理生理学。已证明,作为N-甲基-D-天冬氨酸(NMDA)受体拮抗剂的解离麻醉剂可在健康对照者中产生精神分裂症的所有阴性、精神病性、认知和生理特征。这导致了NMDA受体功能低下在精神分裂症病理生理学中的假说的发展。后来还发现,增强NMDA受体在甘氨酸调节位点功能的药物可改善接受抗精神病药物治疗的精神分裂症患者的症状。因此,氨基酸水平紊乱与精神分裂症的生物学基础和病理生理学之间的关系是一个有待进一步探索的重要领域,以便有效地管理精神分裂症患者。

相似文献

1
Potential role of amino acids in pathogenesis of schizophrenia.氨基酸在精神分裂症发病机制中的潜在作用。
Int J Health Sci (Qassim). 2017 Jul-Sep;11(3):63-68.
2
NMDA receptor and schizophrenia: a brief history.NMDA 受体与精神分裂症:简要的历史。
Schizophr Bull. 2012 Sep;38(5):920-6. doi: 10.1093/schbul/sbs076.
3
[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].[精神分裂症的谷氨酸能假说:氯胺酮的临床研究]
Encephale. 2001 Jan-Feb;27(1):53-9.
4
Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.氯氮平治疗前后难治性精神分裂症患者血浆D-丝氨酸、L-丝氨酸和甘氨酸水平的变化
Neurosci Lett. 2014 Oct 17;582:93-8. doi: 10.1016/j.neulet.2014.08.052. Epub 2014 Sep 10.
5
Associations among plasma markers for N-methyl-d-aspartate receptor hypofunction, redox dysregulation, and insufficient myelination in patients with schizophrenia.精神分裂症患者中N-甲基-D-天冬氨酸受体功能减退、氧化还原失调和髓鞘形成不足的血浆标志物之间的关联。
Heliyon. 2024 Apr 25;10(9):e30193. doi: 10.1016/j.heliyon.2024.e30193. eCollection 2024 May 15.
6
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.谷氨酸与精神分裂症:苯环己哌啶、N-甲基-D-天冬氨酸受体及多巴胺-谷氨酸相互作用
Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5.
7
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia.在精神分裂症病理生理学中N-甲基-D-天冬氨酸受体功能减退的证据不断汇聚。
Ann N Y Acad Sci. 2003 Nov;1003:318-27. doi: 10.1196/annals.1300.020.
8
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.精神分裂症患者与正常对照及重度抑郁症患者血浆甘氨酸和丝氨酸水平比较:与阴性症状的关系
Int J Neuropsychopharmacol. 2004 Mar;7(1):1-8. doi: 10.1017/S1461145703003900. Epub 2004 Jan 13.
9
[NMDA-type glutamate receptor and schizophrenia].[N-甲基-D-天冬氨酸型谷氨酸受体与精神分裂症]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Nov;33(5-6):217-24.
10
Targeting of NMDA receptors in new treatments for schizophrenia.在精神分裂症新疗法中对N-甲基-D-天冬氨酸受体的靶向作用。
Expert Opin Ther Targets. 2014 Sep;18(9):1049-63. doi: 10.1517/14728222.2014.934225. Epub 2014 Jun 26.

引用本文的文献

1
Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics.自闭症谱系障碍中的低代谢:来自大脑和血液转录组学的见解
Mol Neurobiol. 2025 Apr 15. doi: 10.1007/s12035-025-04941-2.
2
Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space Index.基于质子磁共振波谱测量脑大分子和沿血管周围间隙指数的扩散张量图像分析评估精神分裂谱系障碍的糖脂代谢系统。
Schizophr Bull. 2024 Nov 8;50(6):1396-1410. doi: 10.1093/schbul/sbae060.
3
Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.鉴定青少年中重度抑郁症、双相情感障碍和精神分裂症的血浆代谢特征。
Transl Psychiatry. 2024 Mar 26;14(1):163. doi: 10.1038/s41398-024-02886-z.
4
Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review.代谢组学、脂质组学与抗精神病药物:一项系统综述
Biomedicines. 2023 Dec 13;11(12):3295. doi: 10.3390/biomedicines11123295.
5
Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia.GC-MS 应用于寻找精神分裂症低分子量标志物的经验和观点。
Molecules. 2022 Dec 31;28(1):324. doi: 10.3390/molecules28010324.
6
Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains.精神分裂症来源的诱导多能干细胞衍生神经细胞和脑类器官的蛋白质组学特征与患者的死后大脑相似。
Cell Biosci. 2022 Dec 1;12(1):189. doi: 10.1186/s13578-022-00928-x.
7
COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics.新型冠状病毒肺炎疫苗与病毒:对药物代谢动力学和药物代谢的影响。
Drug Metab Dispos. 2023 Jan;51(1):130-141. doi: 10.1124/dmd.122.000934. Epub 2022 Oct 23.
8
Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study.犬尿氨酸途径代谢产物与女性精神分裂症患者奥氮平治疗反应的关系:一项纵向研究。
CNS Neurosci Ther. 2022 Oct;28(10):1539-1546. doi: 10.1111/cns.13895. Epub 2022 Jun 29.
9
l-Cysteine modified metal-organic framework as a chiral stationary phase for enantioseparation by capillary electrochromatography.L-半胱氨酸修饰的金属有机框架作为毛细管电色谱对映体分离的手性固定相。
RSC Adv. 2022 Feb 21;12(10):6063-6075. doi: 10.1039/d1ra07909c. eCollection 2022 Feb 16.
10
Sodium Benzoate-Harmfulness and Potential Use in Therapies for Disorders Related to the Nervous System: A Review.苯甲酸钠的危害及其在神经系统相关疾病治疗中的潜在用途:综述。
Nutrients. 2022 Apr 2;14(7):1497. doi: 10.3390/nu14071497.

本文引用的文献

1
Corrigendum: Homocysteine levels in schizophrenia and affective disorders-focus on cognition.勘误:精神分裂症和情感障碍中的同型半胱氨酸水平——聚焦于认知。
Front Behav Neurosci. 2015 Apr 10;9:81. doi: 10.3389/fnbeh.2015.00081. eCollection 2015.
2
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.精神分裂症辅助治疗的营养干预:简要综述
Nutr J. 2014 Sep 16;13:91. doi: 10.1186/1475-2891-13-91.
3
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.躯体共病及其与精神分裂症死亡率的相关性:一项综合性医院住院患者的 12 年自然随访研究。
Eur Arch Psychiatry Clin Neurosci. 2014 Feb;264(1):3-28. doi: 10.1007/s00406-013-0436-x. Epub 2013 Aug 13.
4
Psychiatric comorbidity among adults with schizophrenia: a latent class analysis.精神分裂症成年患者的精神共病:潜类别分析。
Psychiatry Res. 2013 Nov 30;210(1):16-20. doi: 10.1016/j.psychres.2013.05.013. Epub 2013 May 30.
5
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.精神分裂症患者的合并症和死亡率:一项瑞典全国队列研究。
Am J Psychiatry. 2013 Mar;170(3):324-33. doi: 10.1176/appi.ajp.2012.12050599.
6
Elevated serum levels of homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents.血清同型半胱氨酸水平升高作为儿童和青少年精神疾病的早期预后因素。
Schizophr Res Treatment. 2012;2012:373261. doi: 10.1155/2012/373261. Epub 2012 Oct 2.
7
Revisiting thyroid hormones in schizophrenia.重新审视精神分裂症中的甲状腺激素。
J Thyroid Res. 2012;2012:569147. doi: 10.1155/2012/569147. Epub 2012 Mar 26.
8
Oxidative stress in schizophrenia - focusing on the main markers.精神分裂症中的氧化应激——聚焦主要标志物。
Psychiatr Danub. 2011 Sep;23(3):237-45.
9
L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.赖氨酸辅助治疗精神分裂症患者的单盲、随机、交叉先导研究。
BMC Med. 2011 Apr 18;9:40. doi: 10.1186/1741-7015-9-40.
10
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.乙酰半胱氨酸在精神病学中的应用:现有治疗证据和潜在作用机制。
J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057.